FDA Asks Sanofi to Assess Potential Neurocognitive Side Effects of Experimental Cholesterol Drug

Sanofi confirmed that it has been asked by the USFDA to assess the potential neurocognitive side effects of its experimental cholesterol drug.

Sanofi confirmed that it has been asked by the US Food and Drug Administration to assess the potential neurocognitive side effects of its experimental cholesterol drug which it has developed in partnership with Regeneron Pharmaceuticals.

The drug, alirocumab, belongs to an experimental class known as PCSK9 inhibitors that reduce bad or LDL cholesterol by blocking the PCSK9 protein which is linked with maintaining high levels of the cholesterol in the blood stream.

Low Saturated Fat and Low Cholesterol Diet
To avoid obesity we must consciously control the quantity and the quality of fat that we eat and our daily intake of fat should contribute no more than 25% of our calories.

However the FDA said it was “aware of concerns raised with neurocognitive adverse events” and has asked the two companies to assess the side effects.

Amgen Inc is also developing a similar drug, evolocumab, and the company revealed that it has also been contacted by the agency. “Similar to other companies developing PCSK9 inhibitors, Amgen has been in communication with the FDA, and we will continue to investigate the potential for cognitive impairment in our program”, the company said in a statement.

Source-Medindia

Natural Remedies for Cholesterol � How Effective Are They?
Certain natural remedies are effective in controlling high cholesterol, when aided by lifestyle changes.

High Cholesterol | Hypercholesterolemia - Causes, Symptoms, Diagnosis & Treatment
High cholesterol level in blood are a risk for heart disease and stroke. They get deposited in the wall of the arteries and clog the circulation posing a threat to life.

Cholesterol - Lipoproteins - Functions - Normal Blood Cholesterol Levels - Causes - Treatment - FAQs
Cholesterol is produced by the body (liver) and is essential for normal body functioning.